LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Actinium Pharmaceuticals Inc

Cerrado

1.81 8.38

Resumen

Variación precio

24h

Actual

Mínimo

1.62

Máximo

1.84

Métricas clave

By Trading Economics

Ingresos

-9.3M

-16M

BPA

-0.51

Empleados

31

EBITDA

-9.3M

-17M

Recomendaciones

By TipRanks

Recomendaciones

Compra Fuerte

Estimación a 12 Meses

+255.03% upside

Dividendos

By Dow Jones

Próximas Ganancias

1 ago 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización Mercado

2.2M

51M

Apertura anterior

-6.57

Cierre anterior

1.81

Actinium Pharmaceuticals Inc Gráfico

Resultados pasados no son un indicador fiable de resultados futuros.

Noticias Relacionadas

5 jun 2025, 20:45 UTC

Ganancias

Broadcom 2Q Sales Climb on Booming AI Demand

5 jun 2025, 23:45 UTC

Charlas de Mercado

Nikkei May Decline as Caution Over U.S. Economy Continues -- Market Talk

5 jun 2025, 23:44 UTC

Charlas de Mercado

Gold Edges Higher on Weak U.S. Data -- Market Talk

5 jun 2025, 23:30 UTC

Charlas de Mercado

NZME Cost Cuts Can Cushion Effect of Weak Market -- Market Talk

5 jun 2025, 21:32 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:50 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 jun 2025, 20:45 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:24 UTC

Ganancias

Broadcom Stock Falls Despite Earnings Beat From AI Chip Maker -- Barrons.com

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Cont Ops EPS $1.03 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Rev $15B >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Net $4.97B >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q Adj EPS $1.58 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom 2Q EPS $1.03 >AVGO

5 jun 2025, 20:15 UTC

Ganancias

Broadcom Sees 3Q Rev $15.8B >AVGO

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: Transaction Is Expected to Close in the 4Q >CEG

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: Calpine Deal Clears Texas Regulatory Review

5 jun 2025, 20:11 UTC

Adquisiciones, fusiones, absorciones

Constellation Energy: With Approval From PUCT Secured, Transaction Awaits Clearance From NY State Public Service Commission, Federal Energy Regulatory Commission and DOJ >CEG

5 jun 2025, 19:22 UTC

Charlas de Mercado

Oil Futures Resume Upward Moves -- Market Talk

5 jun 2025, 19:00 UTC

Charlas de Mercado

U.S. Natural Gas Settles Lower in Choppy Trade -- Market Talk

5 jun 2025, 18:32 UTC

Charlas de Mercado

Gold Slips After Trump-Xi Call -- Market Talk

5 jun 2025, 18:26 UTC

Ganancias

These Stocks Are Moving the Most Today: Broadcom, Tesla, Circle, Brown-Forman, MongoDB, Planet Labs, ChargePoint, Ciena, and More -- Barrons.com

5 jun 2025, 18:06 UTC

Charlas de Mercado

Transpacific Ship Freight Rates Spike on China Tariff Truce -- Market Talk

5 jun 2025, 16:30 UTC

Adquisiciones, fusiones, absorciones

Vallourec Completes The Acquisition Of Thermotite Do Brasil >VK.FR

5 jun 2025, 16:20 UTC

Charlas de Mercado

Basic Materials Roundup: Market Talk

5 jun 2025, 16:18 UTC

Charlas de Mercado

U.S. Natural Gas Market Shrugs Off Big Storage Build -- Market Talk

5 jun 2025, 16:15 UTC

Charlas de Mercado

Global Commodities Roundup: Market Talk

5 jun 2025, 16:12 UTC

Charlas de Mercado

Global Energy Roundup: Market Talk

5 jun 2025, 16:12 UTC

Charlas de Mercado

Copper Prices Rise on Positive Signals From Trump on China Trade Talks -- Market Talk

5 jun 2025, 16:03 UTC

Charlas de Mercado

U.S. Diesel, Gasoline Futures Pick Back Up -- Market Talk

5 jun 2025, 15:49 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

Comparación entre iguales

Cambio de precio

Actinium Pharmaceuticals Inc previsión

Precio Objetivo

By TipRanks

255.03% repunte

Estimación a 12 Meses

Media 6 USD  255.03%

Máximo 9 USD

Mínimo 4 USD

De acuerdo con 3 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Actinium Pharmaceuticals Inc Dist en los últimos 3 meses.

Consenso

By TipRanks

Compra Fuerte

3 ratings

3

Comprar

0

Mantener

0

Vender

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Actinium Pharmaceuticals Inc

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. Its Iomab-B is an induction and conditioning agent prior to bone marrow transplant in patients with relapsed and refractory acute myeloid leukemia (r/r AML). The company focuses on advancing its development for product candidate Actimab-A, a therapeutic agent that has demonstrated potential activity in r/r AML patients. In addition, it engages with the National Cancer Institute under the cooperative research and development agreement for the development of Actimab-A in AML and other myeloid malignancies. Its Iomab-ACT, a next generation conditioning candidate, is being developed for improving patient access and outcomes for curative cell and gene therapies. Further, the company's research and development activities primarily focus on advancing various preclinical programs for solid tumor indications. The company holds approximately 235 patents and patent applications, including various patents related to the manufacture of the isotope Ac-225 in a cyclotron. The company is based in New York, New York.